<DOC>
	<DOC>NCT00604409</DOC>
	<brief_summary>This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.</brief_summary>
	<brief_title>Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer</brief_title>
	<detailed_description>Patients with adequate liver function and performance status in whom liver-directed therapy and capecitabine would be appropriate are eligible for this clinical trial.</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Adequate liver function Adequate performance status Significant extrahepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>